Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy

Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy

Triple negative breast cancer (TNBC) has negative expression of ER, PR and HER-2. TNBC shows high histological grade and positive rate of lymph node metastasis, easy recurrence and distant metastasis. Molecular typing based on metabolic genes can reflect deeper characteristics of breast cancer and p...

Full description

Bibliographic Details
Main Authors:	Yu Zhou, Yingqi Che, Zhongze Fu, Henan Zhang, Huiyu Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Public Health
Subjects:	triple-negative breast cancer metabolic genes bioinformatics molecular typing tumor microenvironment immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2022.902378/full

Similar Items

Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jakub Wesolowski, et al.
Published: (2022-08-01)

Advances in immunotherapy for triple-negative breast cancer
by: Yang Liu, et al.
Published: (2023-09-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
by: Elizabeth R. Berger, et al.
Published: (2021-08-01)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
by: Yiwen Zheng, et al.
Published: (2023-06-01)

The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
by: Fan Y, et al.
Published: (2022-01-01)

Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
by: Xupeng Bai, et al.
Published: (2021-09-01)

Progress of Immunotherapy and Its Application in Triple Negative Breast Cancer
by: ZHENG Hongmei, et al.
Published: (2020-11-01)

Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome
by: Liying Li, et al.
Published: (2023-01-01)

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
by: Shaojun Hu, et al.
Published: (2021-11-01)

Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance
by: Chanjuan Zheng, et al.
Published: (2023-07-01)

Metabolic Reprogramming in Triple-Negative Breast Cancer
by: Xiangyu Sun, et al.
Published: (2020-03-01)

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
by: Karan Mediratta, et al.
Published: (2020-11-01)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
by: Sotiris Loizides, et al.
Published: (2023-01-01)

Regulation of ferroptosis‐related genes in CD8+ NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer
by: Zheming Liu, et al.
Published: (2023-12-01)

Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer
by: Shengnan Sha, et al.
Published: (2022-08-01)

Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer
by: Alyssa Vito, et al.
Published: (2021-05-01)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
by: Hongmei Zheng, et al.
Published: (2021-07-01)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
by: Ji Liu, et al.
Published: (2022-08-01)

Recent advances in triple negative breast cancer: the immunotherapy era
by: Antonio Marra, et al.
Published: (2019-05-01)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
by: Gyöngyi Munkácsy, et al.
Published: (2023-04-01)

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
by: Adviti Naik, et al.
Published: (2020-11-01)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
by: Adviti Naik, et al.
Published: (2019-08-01)

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer
by: Toshiaki Iwase, et al.
Published: (2021-09-01)

Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer
by: Gu F, et al.
Published: (2022-09-01)

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges
by: Xiaoxiao Wang, et al.
Published: (2023-01-01)

Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential
by: Brooke E. Wilson, et al.
Published: (2023-03-01)

Systematic evaluation of tumor microenvironment and construction of a machine learning model to predict prognosis and immunotherapy efficacy in triple-negative breast cancer based on data mining and sequencing validation
by: Qiheng Gou, et al.
Published: (2022-09-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

Immunoadjuvant Nanoparticles as Trojan Horses for Enhanced Photo-Immunotherapy in the Treatment of Triple-Negative Breast Cancer
by: Jinxian Wu, et al.
Published: (2022-05-01)

Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer
by: Han Gong, et al.
Published: (2024-01-01)

Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer
by: Shaoquan Zheng, et al.
Published: (2020-11-01)

Immunotherapeutic interventions of Triple Negative Breast Cancer
by: Zehuan Li, et al.
Published: (2018-05-01)

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer
by: Vincent K. Tuohy, et al.
Published: (2016-06-01)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
by: Xiaorui Sun, et al.
Published: (2022-11-01)

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by: Onyinyechi Obidiro, et al.
Published: (2023-06-01)

Advances in Combined Immunotherapy for Triple Negative Breast Cancer
by: WANG Hua, et al.
Published: (2022-10-01)

Comprehensive analysis of glycolysis mediated pattern clusters and immune infiltration characterization of tumor microenvironment in triple-negative breast cancer
by: Ji Liu, et al.
Published: (2023-04-01)

Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment
by: Getinet M. Adinew, et al.
Published: (2021-12-01)

Heterogeneity derived from 18F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients
by: Yizhao Xie, et al.
Published: (2022-05-01)

Identification of long non-coding RNA signatures in triple-negative breast cancer
by: Tian Tian, et al.
Published: (2018-07-01)